A low dose of an antidepressant is generally the starting dose prescribed when you first begin treatment, or a dose deliberately kept below the standard therapeutic range. The exact milligrams depend entirely on which medication you’re taking, since each antidepressant has its own dosing scale. What counts as “low” for one drug might be a full therapeutic dose for another.
The term also applies to doses used for purposes other than depression, like chronic pain or sleep problems, where much smaller amounts are effective. Understanding these ranges can help you make sense of what your prescription actually means.
Low Doses for Common SSRIs
SSRIs are the most widely prescribed antidepressants, and their standard daily doses serve as the benchmark. A 2023 systematic review in BMJ Medicine confirmed that the optimal starting doses for the major SSRIs are: 20 mg for fluoxetine, citalopram, and paroxetine; 50 mg for sertraline; and 10 mg for escitalopram. These are also considered the standard therapeutic doses, meaning they provide the best balance of effectiveness and tolerability for most people.
A “low dose” of an SSRI typically means anything below those numbers. For sertraline, that would be 25 mg. For fluoxetine or citalopram, 10 mg. For escitalopram, 5 mg. Doctors often start at these reduced doses for a week or two to let your body adjust before moving up to the standard dose, especially if you’re prone to side effects or have a history of anxiety (since SSRIs can temporarily increase anxiety in the first days of treatment).
Low Doses for SNRIs and Tricyclics
SNRIs follow a different scale. Venlafaxine starts at 75 mg daily, with a maintenance range of 225 to 375 mg, so anything under 75 mg qualifies as low. Duloxetine starts at 30 mg, with 60 mg as the standard maintenance dose. Desvenlafaxine starts at 25 to 50 mg, with 50 mg also serving as the maintenance dose, making it one of the few antidepressants where the starting dose and the target dose are the same.
Tricyclic antidepressants have a much wider dosing range, which is part of why “low dose” gets used so often with this class. Amitriptyline starts at 50 mg for depression, with maintenance doses of 100 to 200 mg. Nortriptyline starts at 25 mg, with maintenance of 50 to 150 mg. But when tricyclics are prescribed for pain, insomnia, or migraine prevention, the doses used are dramatically lower than what’s needed for depression.
Why Low Doses Still Have Real Effects
Brain imaging studies help explain why even small amounts of an antidepressant do something meaningful. Antidepressants work by blocking the serotonin transporter, the protein that reabsorbs serotonin after it’s released. PET imaging research published in Molecular Psychiatry found that the relationship between dose and transporter blockade follows a curve: occupancy increases rapidly at lower doses, then flattens out. At the usual minimum recommended dose for depression, roughly 80% of serotonin transporters are already blocked.
This means that half of the standard dose doesn’t give you half the effect. For most antidepressants studied, 50% transporter occupancy occurred at doses well below half of the lowest manufactured pill. Even at or below the smallest available tablet, there is considerable biological activity happening. This is why low doses aren’t “nothing doses.” They produce real changes in brain chemistry, just not always enough to fully treat moderate or severe depression on their own.
Low Doses for Pain and Sleep
Some of the most common uses of low-dose antidepressants have nothing to do with depression. Tricyclics in particular are frequently prescribed at a fraction of their antidepressant dose for chronic pain conditions, nerve pain, fibromyalgia, and sleep problems. A Cochrane review classified amitriptyline doses under 25 mg as “low” for pain management. Studies have used doses as small as 5 mg of amitriptyline for neck pain and 25 mg for fibromyalgia. For context, the depression starting dose for amitriptyline is 50 mg, and maintenance doses can reach 200 mg.
Duloxetine follows a similar pattern. For pain conditions like diabetic neuropathy, study doses have gone as low as 20 mg daily, compared to the standard 60 mg used for depression. Venlafaxine has been studied at 37.5 mg for facial pain, which is half its usual starting dose for depression. At these levels, the medications appear to work through different pathways than they do at full antidepressant doses, affecting pain signaling and sleep architecture rather than primarily targeting mood.
Effectiveness of Low Doses for Depression
A BMJ meta-analysis pooling 35 studies and over 2,000 participants found that tricyclic antidepressants at doses below the recommended range were more effective than placebo for treating depression. They were possibly slightly less effective than standard doses, but the trade-off was meaningful: people on lower doses dropped out of studies due to side effects at significantly lower rates than those on standard doses.
This finding matters if you’re weighing the cost of side effects against the benefit of treatment. For mild to moderate depression, a low dose may provide enough improvement with fewer problems like dry mouth, weight changes, drowsiness, or sexual side effects. For more severe depression, most evidence supports working up to the standard therapeutic dose, since that 80% transporter occupancy threshold appears to be where the full antidepressant effect kicks in.
How Long Low Doses Take to Work
Regardless of the dose, antidepressants take time. Standard antidepressants typically require about two weeks before any improvement becomes noticeable, and roughly a month or more for the full effect to develop. If you’re starting at a low dose with plans to increase, the clock largely resets with each dosage change, since your brain needs time to adjust to the new level of transporter blockade.
This timeline can feel frustrating, especially when you’re starting at a deliberately low dose and know an increase is coming. The waiting period exists because antidepressants don’t just change serotonin levels overnight. Your brain gradually adapts its receptor sensitivity and signaling patterns, and that biological remodeling takes weeks. During this initial period, you may notice side effects before you notice any mood improvement, which is normal and not a sign the medication isn’t working.
Low Doses During Tapering
Low doses also play a critical role when coming off antidepressants. Because of the same curved relationship between dose and brain effect, reducing from 20 mg to 10 mg of an SSRI produces a much larger drop in transporter blockade than reducing from 40 mg to 30 mg. This is why withdrawal symptoms tend to hit hardest during the final stages of discontinuation.
A method called hyperbolic tapering addresses this by making each dose reduction smaller as the total dose gets lower. Instead of cutting your dose in half and then stopping, you might go from 10 mg to 5 mg, then 2.5 mg, then 1.25 mg over several weeks or months. Each step produces a roughly equal change in actual brain activity, keeping withdrawal symptoms more manageable. This approach often requires liquid formulations or pill splitting, since most antidepressants aren’t manufactured in the very small doses needed for the final tapering steps.
Who Gets Started on Low Doses
Certain groups are more likely to begin at the low end. Older adults are routinely started on reduced doses because they metabolize medications more slowly, meaning the same pill produces higher blood levels and stronger effects. The clinical principle of “start low and go slow” is standard practice for this population. People with anxiety disorders also often start below the usual dose, since the early activation effects of antidepressants (feeling jittery, restless, or more anxious in the first week) tend to be more pronounced in people who are already anxious.
If you’re sensitive to medications in general, have a history of stopping antidepressants because of side effects, or are taking other medications that could interact, your prescriber may also choose a lower starting point. The goal is the same: get to a dose that works while minimizing the bumps along the way.